{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T14:15:20Z","timestamp":1648822520382},"reference-count":8,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.medcli.2008.11.015","type":"journal-article","created":{"date-parts":[[2009,9,23]],"date-time":"2009-09-23T16:03:48Z","timestamp":1253721828000},"page":"756-757","source":"Crossref","is-referenced-by-count":3,"title":["Eplerenona en hipertensi\u00f3n arterial resistente con intolerancia previa a espironolactona"],"prefix":"10.1016","volume":"132","author":[{"given":"Jos\u00e9","family":"Antonio Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Rodilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"P\u00e9rez-Lahiguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Mar\u00eda Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2008.11.015_bib1","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","year":"2007","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.medcli.2008.11.015_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1157\/13076402","article-title":"Gu\u00eda sobre el diagn\u00f3stico y tratamiento de la hipertensi\u00f3n arterial en Espa\u00f1a 2005","volume":"125","author":"Mar\u00edn","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2008.11.015_bib3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2008.11.015_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/00129784-200505010-00007","article-title":"Eplerenone: a review of its use in essential hypertension","volume":"5","author":"Croom","year":"2005","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.medcli.2008.11.015_bib5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1157\/13126215","article-title":"Respuesta antihipertensiva a la espironolactona en pacientes con hipertensi\u00f3n arterial refractaria","volume":"131","author":"Rodilla","year":"2008","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2008.11.015_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0300-8932(09)70158-7","article-title":"Uso de espironolactona o doxazosina en la hipertensi\u00f3n arterial refractaria","volume":"62","author":"Rodilla","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.medcli.2008.11.015_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0895-7061(01)02342-1","article-title":"The role of spironolactone in the treatment of patients with refractory hypertension","volume":"15","author":"Ouzan","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.medcli.2008.11.015_bib8","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775308002303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775308002303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,16]],"date-time":"2018-12-16T08:24:01Z","timestamp":1544948641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775308002303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":8,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0025775308002303"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2008.11.015","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}